CDI Raises $43M in IPO
Cellular Dynamics International‘s initial public offering raised $43 million, after deducting underwriting discounts and commissions, the company announced today. Sales of the stock (ICEL) began on July 25. According to a…
Cellular Dynamics International‘s initial public offering raised $43 million, after deducting underwriting discounts and commissions, the company announced today. Sales of the stock (ICEL) began on July 25. According to a…
Cellular Dynamics International, Inc., will price its 3,846,000 shares of common stock at $12 per share, the company announced today. The shares will begin trading on Thursday on the Nasdaq Global…
The Wisconsin Alumni Research Foundation (WARF) issued the fourth most university biotechnology patents in the United States and Europe between 2008 and 2012, according to Bioentrepreneur. Data in Bioentrepreneur said…
For years, scientists have used animals to imitate human diseases. Now scientists are using the induced pluripotent stem cell (iPS cell) that develops specialized cells as functional models of human…
Cellular Dynamics International announced this week that it has filed with the SEC for an initial public offering of common stock. The company founded by stem cell pioneer James Thomson develops…
Rats used to model ALS saw improved muscle function and survival after being injected with human stem cells, the University of Wisconsin School of Veterinary Medicine revealed recently. Masatoshi Suzuki,…
Su-Chun Zhang and his team of University of Wisconsin researchers have successfully converted skin cells to nervous system cells directly, the university announced recently. Skipping the induced pluripotent stem cell (iPSC) stage…
The University of Wisconsin revealed recently a study that is the first to show results suggesting human stem cells have the ability to successfully implant themselves in the human brain…
A preliminary examination of Exact Sciences‘ Cologuard colorectal cancer screening test showed promising data for detection of colorectal cancer and pre-cancerous polyps, the company announced recently. “There is a significant unmet clinical…
After a new type of “bird flu” emerged in China, University of Wisconsin researcher Yoshihiro Kawaoka and his company FluGen began working to make flu vaccines more effective than ever, the university announced…